Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Reporting person: Winnie Ling, Head of Legal and People and officer of Blend Labs, Inc. (BLND), reported a sale of common stock executed under a Rule 10b5-1 trading plan adopted on 03/14/2025.
The Form 4 shows a disposition of 4,000 shares of Class A common stock on 10/02/2025 for a weighted average sale price of $3.5845 per share (sales ranged from $3.545 to $3.65). After the reported sale, the reporting person beneficially owned 384,631 shares, held directly.
Blend Labs, Inc. outlined a transition for its previous Head of Finance and Administration, Amir Jafari. His employment ends on October 3, 2025, after which he will serve as a strategic advisor to the Head of Blend and the company through January 1, 2026.
During this advisor period, Jafari will receive payments equivalent to his regular base salary and company-paid COBRA benefits, and his outstanding equity awards will continue to vest under their existing terms. After the advisor period, and subject to his compliance with the transition terms and signing a supplemental release, he will receive an additional $200,000.
If, at any time during the advisor period, the closing price of Blend’s Class A common stock reaches at least $7.00 per share, then 325,000 performance-based restricted stock units from his March 13, 2025 grant will vest upon the effectiveness of the supplemental release.
Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 4,000 common shares through Charles Schwab & Co., Inc. with an approximate sale date of 10/02/2025 on the NYSE. The shares were acquired on 02/20/2025 as the lapse of restricted stock under the company’s equity compensation plan and were paid by equity compensation.
The filing also lists multiple recent open-market sales by (and an address for) Winnie Ling across July–September 2025, each showing trade dates, share amounts, and gross proceeds. The Form 144 includes the seller’s representation that they are not aware of undisclosed material adverse information about the issuer.
Winnie Ling, Head of Legal and People at Blend Labs, Inc. (BLND), reported a sale of 6,500 shares of Class A common stock on 09/18/2025. The shares were sold under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, at a weighted average price of $4.2951 per share (sales ranged from $4.265 to $4.30). After the transaction, the reporting person beneficially owned 388,631 shares, held directly. The Form 4 was signed on 09/19/2025 and includes an offer to provide detailed per-price sale quantities to the Commission staff on request.
Form 144 notice for Blend Labs, Inc. (BLND)
This filing discloses a proposed sale of 6,500 common shares to be executed on 09/18/2025 through Charles Schwab & Co., with an aggregate market value listed as $27,918.00. The shares were acquired by the seller on 05/20/2024 via a restricted stock lapse as equity compensation from Blend Labs, Inc. The filing also reports prior sales by the same person, Winnie Ling, totaling 45,500 shares sold across seven transactions between 07/03/2025 and 09/05/2025, with aggregate gross proceeds of $169,091.00. The filer certifies no undisclosed material adverse information and follows Rule 144 disclosure requirements.
Blend Labs insider sale under 10b5-1 plan — Brian Kneafsey, Head of Revenue and an officer of Blend Labs (BLND), reported a sale of 25,000 shares of Class A common stock on 09/15/2025. The sale was executed under a Rule 10b5-1 trading plan adopted March 14, 2025, and the weighted average sale price for the block was $4.3628 per share, with individual trade prices ranging from $4.32 to $4.40. After the transaction, Kneafsey beneficially owned 712,909 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Form 144 filed for Blend Labs, Inc. (BLND) reporting a proposed sale of 25,000 common shares through Charles Schwab & Co., Inc. with an approximate aggregate market value of $109,069 and an approximate sale date of 09/15/2025 on the NYSE. The filer shows these 25,000 shares were acquired on 02/17/2020 by exercise and held, with payment in cash. The filing lists prior dispositions by Brian Kneafsey totaling 175,000 shares sold between 06/16/2025 and 08/15/2025 for aggregate gross proceeds of $575,145. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Oxana Tkach, Principal Accounting Officer at Blend Labs, Inc. (BLND), reported an insider sale executed under a pre-established Rule 10b5-1 plan. On 09/05/2025 the Form 4 discloses the disposition of 101,429 shares of Class A common stock at a weighted average sale price of $4.0026 per share. Following the reported sales, the filing states the reporting person beneficially owned 52,780 shares as a direct holder. The Form 4 was signed by attorney-in-fact Winnie Ling on 09/09/2025. The filing notes the 10b5-1 plan was adopted on March 14, 2025, and the sale price range realized was $4.00 to $4.005 per share.
Blend Labs insider sale reported. Director Eric H. Woersching sold 20,000 shares of Class A common stock on 09/05/2025 at $4.005 per share under a Rule 10b5-1 trading plan adopted March 4, 2025. After the reported sale he beneficially owns 30,000 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/09/2025. The filing discloses the sale was executed pursuant to an established written plan; no other transactions, grants, or derivative positions are listed.
Blend Labs, Inc. insider transactions: Winnie Ling, Head of Legal and People and an officer of Blend Labs (BLND), reported two open-market sales under a Rule 10b5-1 trading plan adopted March 14, 2025. On 09/04/2025 she sold 4,000 shares at a weighted-average price of $3.5076, leaving 412,631 shares beneficially owned. On 09/05/2025 she sold 17,500 shares at a weighted-average price of $4.0036, leaving 395,131 shares beneficially owned. The Form 4 discloses the weighted-average price ranges for each sale and states the seller will provide detailed per-price allocations upon request.